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Abstract Vitamin K-dependent protein S, which is a cofactor
for activated protein C and thus important for down-regulation
of the coagulation cascade, contains several Ca2+-binding sites
with unusually high affinity. The 89 amino acid fragment
constituting the third and fourth epidermal growth factor-like
(EGF) modules of protein S is the smallest fragment that retains
high-affinity Ca2+ binding and is therefore useful for investigat-
ing the structural basis of this property. Heteronuclear multi-
dimensional nuclear magnetic resonance experiments were used
to obtain extensive assignments of the 1H, 15N and 13C
resonances of the module pair with one Ca2+ bound in EGF 4.
In addition, nearly complete assignments of the 1H resonances of
the isolated Ca2+-free EGF 3 module were obtained. The
assignment process was complicated by broadening of several
resonances, spectral heterogeneity caused by cis-trans isomerisa-
tion of the peptide bond preceding Pro-168, and dimerisation.
Analysis of weighted average secondary chemical shifts, 3JHNHK
coupling constants, and NOE connectivities suggest that both
EGF modules in this fragment adhere to the classical secondary
structure of EGF modules, consisting of one major and one minor
anti-parallel L-sheet. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Blood coagulation is activated as a response to vascular
injury and leads to the activation of platelets and coagulation
proteins which ultimately lead to the formation of a ¢brin
plug [1]. This process is regulated by an anticoagulant coun-
terpart, the so-called protein C anticoagulant system [2]. Ac-
tivated protein C (APC) catalyses the proteolytic degradation
of activated factors V and VIII, which have a crucial role in
the maintenance of the coagulation cascade. Vitamin K-de-
pendent protein S acts as a cofactor for APC. Protein S is a
mosaic protein composed of an N-terminal Gla module, a
region sensitive to cleavage by thrombin and factor Xa, four
epidermal growth factor-like (EGF) modules, and a module
homologous with a steroid hormone-binding protein in plas-
ma [3^5]. The three C-terminal EGF modules have a consen-
sus sequence for Ca2 binding [6^9]. It has also been shown
that they bind Ca2 with relatively high a⁄nity and that the
a⁄nity is dependent on neighbouring modules. The strongest
binding site in recombinant EGF 1^4 has a dissociation con-
stant Kd = 20U1039 M, and this site is probably located in
EGF 4 [10]. However, the isolated EGF 4 module has only a
Kd of 8.6U1033 M, i.e. a 106 times weaker binding, indicating
that neighbouring modules are necessary for high-a⁄nity
Ca2 binding [11]. The smallest fragment that retains rela-
tively high Ca2 a⁄nity is the EGF 3^4 module pair (pS
EGF 3^4), which has a Kd for Ca2 binding to the site in
EGF 4 of 1U1036 M [12]. By studying the e¡ects of Ca2
binding and determining of the structure and the dynamics of
this module pair we hope to be able to explain the structural
basis of the unusually high Ca2 a⁄nity of certain EGF mod-
ules in protein S and the role of metal binding and inter-
module interactions in this context. In this paper we report
the assignments of 1H, 15N, and 13C resonances of recombi-
nant pS EGF 3^4 with one bound Ca2, as well as the 1H
resonances of the Ca2-free, isolated EGF 3 module (pS EGF
3). Both proteins were folded to a native conformation.
2. Materials and methods
The production of pS EGF 3^4 and pS EGF 3 has been described
previously [11,12]. In brief, pS EGF 3^4 was expressed in Escherichia
coli BL21(DE3) pLysS cells as a fusion protein with a His tag. The
recombinant protein was reduced and refolded in vitro, the correctly
folded material was puri¢ed and the His tag removed. Ca2-free pS
EGF 3^4 was lyophilised and characterised by SDS^PAGE, reverse-
phase high-performance liquid chromatography (HPLC), amino acid
composition, and immunoblotting using a monoclonal antibody that
recognises a conformation-dependent epitope. Agarose gel electropho-
resis in the presence and absence of Ca2 was used to detect correctly
folded Ca2-binding pS EGF 3^4. N-terminal sequencing and mass
spectroscopy indicated a homogeneous protein (MW = 9843 Da). The
sequence of the ¢nal product comprised residues 159^245 of human
protein S with the addition of an N-terminal dipeptide (His^Met)
derived from the His tag.
The EGF 3 module, residues Lys-159^Ile-203, was synthesised using
Fmoc chemistry on a Milligen/Biosearch 9050 peptide synthesiser. The
peptide was deprotected, cleaved from the resin, extracted and dried.
Thereafter the peptide was puri¢ed by HPLC performed under reduc-
ing conditions. Fractions with the correct sequence and amino acid
composition were refolded as previously described [11]. Finally, the
refolded peptide was puri¢ed by reversed-phase HPLC. Amino acid
analysis, N-terminal sequencing and electrospray mass spectrometric
analysis gave the expected results.
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 6 3 6 - 7
*Corresponding author. Fax: (46)-46-222 45 43.
E-mail: andreas.muranyi@fkem2.lth.se
1 Present address: Departments of Medical Genetics and Biochemis-
try, Medical Sciences Building, University of Toronto, Toronto, Ont.,
Canada M5S 1A8.
2 Present address: BioInvent Therapeutic AB, So«lvegatan 41, S-223
70 Lund, Sweden.
FEBS 23761 8-6-00
FEBS 23761 FEBS Letters 475 (2000) 135^138
Samples for nuclear magnetic resonance (NMR) spectroscopy were
prepared by dissolving unlabelled, 15N-labelled, and 15N,13C-labelled
pS EGF 3^4 and unlabelled pS EGF 3 in 90%/10% H2O/D2O (or
100% D2O), 0.1 mM NaN3, and 1 mM DSS. Protein concentrations
were in the range 0.5^2 mM. One equivalent CaCl2 was added to the
pS EGF 3^4 samples, leading to saturation of the high-a⁄nity Ca2-
binding site in EGF 4, while pS EGF 3 samples were Ca2-free [13].
All NMR experiments were performed at 36‡C on a Varian Unity
Inova with a 1H frequency of 599.89 MHz using inverse or triple-
resonance probes equipped with pulsed ¢eld gradient coils in the z-
direction.
Using the unlabelled samples of pS EGF 3^4 and pS EGF 3 we
recorded NOESY spectra [14], with mixing times of 80 and 150 ms,
and TOCSY spectra [15], with 40 and 110 ms DIPSI isotropic mixing
times. On the 15N-labelled pS EGF 3^4 we acquired the following
spectra for assignment purposes: 1H,15N HSQC, 1H,15N TOCSY-
HSQC, with a DIPSI mixing sequence (40^110 ms), and 1H,15N NO-
ESY-HSQC, with mixing times of 80 and 150 ms. Several 15N spin
relaxation experiments were also run, for which the details have been
reported previously [13]. To determine 3JHNHK coupling constants
HMQC-J experiments were run and the peak heights were ¢tted as
a function of dephasing time to equation 4 of Kuboniwa et al. [16].
HNCA [17], HN(CO)CA [17,18], HNCACB [19^21], and HNCO
[19,20,22,23] experiments were carried out on the 15N,13C-labelled
pS EGF 3^4 to obtain an unambiguous assignment of backbone
and CL resonances. All double- and triple-resonance experiments, ex-
cept the HMQC-J, were performed with gradient selection of coher-
ences and sensitivity enhancement [24]. Quadrature detection in F1
was achieved by the States-TPPI method [25].
Data were processed using FELIX (Molecular Simulations Inc.,
San Diego, CA, USA). 1H chemical shifts were referenced to DSS
at 0.00 ppm, and 15N and 13C shifts were indirectly referenced using
the frequency ratio gN/gH = 0.101329118 and gC/gH = 0.251449530,
respectively [26]. Spectral display and peak picking were performed
in FELIX or XEASY [27]. Sequential assignments were made in the
3D spectra using functionalities in XEASY and with the aid of a
program for amino acid identi¢cation based on CK and CL chemical
shifts [28]. Peaks in the 3D 1H,15N NOESY-HSQC spectra were in-
tegrated with SPSCAN [29] and calibrated using DYANA [30].
Weighted average secondary chemical shifts (WASS) were calculated
using the program GENXPK [31], employing the following weighting
factors: HK 30.1, CK +0.7, CL -0.7, CP +0.5, Pro CK +4.0, Pro CL
34.0, and Pro CP +4.0.
3. Results and discussion
The assignment process was more complicated than antici-
pated. Extensive line broadening due to chemical exchange
was observed for several resonances, particularly in the N-
terminal part of EGF 3. This rendered signals very weak for
a number of spin systems, most notably Phe-183^Glu-186 in
the second strand of the ¢rst anti-parallel L-sheet. Very slow
exchange caused by cis-trans isomerisation of the Lys-167^
Pro-168 peptide bond gave rise to extensive heterogeneity in
all spectra. In a 1H,15N HSQC spectrum of pS EGF 3^4 with
one equivalent of Ca2, 124 peaks instead of the expected 99
were observed. For 23 residues in EGF 3 two separate sets of
spin systems, originating from the cis and trans forms, respec-
tively, were assigned. Finally, an estimate of the correlation
time of rotational di¡usion (dc) suggested that pS EGF 3^4
probably was present as a dimer with MWV20 kDa at 0.5
mM protein concentration. These ¢ndings have been de-
scribed in detail elsewhere [13].
The triple-resonance experiments were used to sequentially
assign EGF 4 and most parts of EGF 3. An example of strips
from the HNCACB spectrum is shown in Fig. 1. The assign-
ment was con¢rmed by sequential NOEs in the 1H,15N NO-
ESY-HSQC spectrum. However, in EGF 3 several signals
were missing in the triple-resonance spectra. The lack of ob-
servable signals in the triple-resonance spectra coincides with
a region of the protein exhibiting extensive 15N line broad-
ening (Rex) (Fig. 2) [13]. A region (residues 228^235) in the C-
terminal part of the protein also exhibits extensive 15N line
broadening but this does not have the same deleterious e¡ect
on the triple-resonance spectra. However, in the N-terminal
part the 15N Rex terms are accompanied by 1H line broad-
ening to some extent. Thus it is likely that the lack of signals
from residues in the N-terminal part is the result mainly of the
combination of 1H and 15N line broadening. Additional loss
of signal intensity is caused by the fact that many spin systems
in EGF 3 (residues 159^200) are doubled due to the cis-trans
isomerisation of the Lys-167^Pro-168 peptide bond. Parts of
EGF 3 was therefore assigned relying only on the 1H,15N
TOCSY-HSQC and NOESY-HSQC spectra.
The secondary structure was inferred from a combination
of WASSs [32], 3JHNHK scalar coupling constants [33], and
characteristic NOEs [34] (Fig. 3). The data for the two EGF
modules are similar and consistent with the classical fold of
EGF modules [35]. It consists of a centrally located major
(residues 173^179 and 182^188 in EGF 3, and 213^218 and
222^227 in EGF 4) and a C-terminal minor (residues 190^192
and 199^201 in EGF 3, and 232^235 and 241^244 in EGF 4)
anti-parallel L-sheet. In addition, there are short, helical turns
centred around the ¢rst cysteine residue in each module (res-
Fig. 1. Strips from the HNCACB experiments showing CK (solid
line) and CL (broken line) connectivities from Pro-188^Lys-198. In
this section the only missing connectivity is Ser-197 CL^Lys-198 CL
(indicated by a circle).
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idues 163^165 and 205^207 in EGF 3 and EGF 4, respec-
tively).
In the paper describing the structure of the module pair of
Ca2-binding EGF modules 32^33 from ¢brillin-1, a hydro-
phobic cluster linking the two EGF modules was described
[36]. In pS EGF 3^4 Tyr-191, Pro-219 and Gly-220 corre-
spond to the residues involved in this hydrophobic module^
module contact in ¢brillin-1. In order to probe whether a
similar hydrophobic cluster was present in pS EGF 3^4, we
compared the chemical shifts of the EGF 3 module in pS EGF
3^4 with those of pS EGF 3. Shift di¡erences were indeed
found in the expected region but they were relatively small.
The two C-terminal residues of pS EGF 3 (Asp-202 and Ile-
203) displayed shift di¡erences of about 0.3 ppm, which is
most likely an end e¡ect. Thereafter the largest shift di¡erence
was observed for the Arg-192 HO (0.22 ppm). Shift di¡erences
between 0.10 and 0.16 ppm were seen for Gly-190, Tyr-191,
Arg-192, Tyr-193, Asn-194, Lys-196, and Cys-200. Upon
Ca2 binding to the proximal, high-a⁄nity site in EGF 4
we observed 1H shift changes for the latter residues in the
range 0.04^0.08 ppm, which, although small, were signi¢cant
[13]. These relatively small shift di¡erences can hardly be tak-
en as proof that a hydrophobic cluster, similar to the one
observed in the ¢brillin EGF module pair, exists in pS EGF
3^4, but are certainly consistent with the presence of such a
contact.
4. Data deposition
Chemical shifts of the 1H resonances from pS EGF 3 and
the 1H, 15N, 13CK, 13CL, and 13CP resonances of pS EGF 3^4
have been deposited in the BioMagResBank database under
Fig. 3. The WASS of HK, CK, CL and CP nuclei, 3JHNHK coupling constants (3JHNHK6 6 Hz, R ; 3JHNHKs 8 Hz, S ; 6 Hz6 3JHNHK6 8 Hz,
a ; 3JHNHK that could not be measured, U ; and proline residue, P) and characteristic NOEs of regular secondary structure (the width of the
bar indicates the strength of the NOE). At the top the inferred secondary structure is indicated by ¢lled rectangles (helices) and arrows
(L-sheets). For residues Tyr-222 and Leu-234 the WASS indicates L-sheet, while 3JHNHK is 5.1 Hz, which is not consistent with a L-sheet. To
be able to pair the strands these residues were included in L-sheet structure, although the symbols at the top were drawn with a broken line to
indicate this slight inconsistency.
Fig. 2. The residue-speci¢c chemical exchange contributions calcu-
lated as Rex = R23[Rxy/Rz(R131.249cNH)+1.079cNH], where R1 and
R2 are the longitudinal and transverse 15N relaxation rate constants,
respectively, Rz and Rxy are the longitudinal and transverse cross-
correlation relaxation rate constants resulting from 1H-15N dipolar
and 15N chemical shift anisotropy interference, and cNH is the het-
eronuclear cross-relaxation rate [13,37]. Residues for which no reli-
able Rz or Rxy could be measured due to 1H line broadening or
spectral overlap are indicated by a triangle or a circle, respectively.
At the top of the ¢gure assignments of the chemical shifts of CL,
CK, and CP in triple-resonance experiments are indicated by a
square.
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the accession numbers 4728 and 4729, respectively. For both
proteins the shifts of the trans as well as cis Lys-167^Pro-168
forms are deposited.
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